Evaluation of the Effectiveness of the Pecha Kucha-Supported Microteaching Method in Nursing Process Education
30 de junio de 2026 actualizado por: Sevim Uzuncan, Istanbul University - Cerrahpasa
This randomized controlled study aims to evaluate the effectiveness of the Pecha Kucha-supported microteaching method in nursing process education among first-year nursing students.
Participants will be randomly assigned to either an intervention group receiving Pecha Kucha-supported microteaching or a control group receiving traditional instruction.
The effects of the intervention on nursing process competencies and learning motivation will be evaluated.
Descripción general del estudio
Estado
Activo, no reclutando
Condiciones
Intervención / Tratamiento
Descripción detallada
The nursing process is a systematic and scientific method that guides nursing care. Developing nursing students' competencies in the nursing process is essential for providing high-quality patient care. Innovative teaching methods may enhance students' learning experiences and improve educational outcomes.
This randomized controlled study aims to evaluate the effectiveness of the Pecha Kucha-supported microteaching method in nursing process education among first-year nursing students. Participants will be randomly assigned to an intervention group or a control group. The intervention group will receive Pecha Kucha-supported microteaching, while the control group will receive traditional instruction. Following the educational intervention, students will prepare nursing care plans during their clinical practice.
Outcomes will be evaluated using a Nursing Process Knowledge Form, the Instructional Materials Motivation Survey, and the Quality of Nursing Diagnoses, Interventions and Outcomes (Q-DIO) instrument. The study will assess the effects of the intervention on nursing process competencies and learning motivation.
Tipo de estudio
Intervencionista
Inscripción (Actual)
100
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Avcılar
-
Istanbul, Avcılar, Turquía (Türkiye), 34310
- Istanbul University-Cerrahpasa, Florence Nightingale Faculty of Nursing
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- First-year nursing students
- Successfully completed prerequisite nursing courses
- Grade point average (GPA) of 1.80 or higher
- Voluntary agreement to participate in the study
- Providing written informed consent
Exclusion Criteria:
- Students repeating the course
- Graduates of Vocational School of Health Services programs
- Withdrawal from the study at any stage
- Failure to complete study assessments or data collection forms
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Experimental Group
Nursing students who received a brief refresher lecture on the nursing process and participated in Pecha Kucha-supported microteaching activities based on case scenarios.
Students subsequently prepared individual nursing care plans during clinical practice.
|
Nursing students first received a brief refresher lecture on the nursing process.
The experimental group, consisting of 50 students, was then divided into five groups of 10 students each.
Each group was assigned a case scenario and a nursing diagnosis.
Students were asked to prepare a presentation using the Pecha Kucha-supported microteaching method based on the assigned case and nursing diagnosis.
One student from each group delivered the presentation on behalf of the group.
Feedback sessions were conducted following the presentations.
Subsequently, students prepared individual nursing care plans for patients cared for during clinical practice.
|
|
Comparador activo: Control Group
Nursing students who received a brief refresher lecture on the nursing process and prepared group nursing care plans based on case scenarios.
Students subsequently prepared individual nursing care plans during clinical practice.
|
Nursing students first received a brief refresher lecture on the nursing process.
The control group, consisting of 50 students, was then divided into five groups of 10 students each.
Each group was assigned a case scenario and a nursing diagnosis.
Students were asked to collaboratively prepare a nursing care plan based on the assigned case and nursing diagnosis.
Following this activity, students prepared individual nursing care plans for patients cared for during clinical practice.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Quality of Nursing Diagnoses, Interventions and Outcomes
Periodo de tiempo: After completion of the educational intervention (approximately 4 weeks after baseline) and at the end of the clinical practice period (approximately 12 weeks after baseline).
|
The quality of nursing care plans will be evaluated using the Quality of Nursing Diagnoses, Interventions and Outcomes (Q-DIO) instrument.
The Q-DIO is a 29-item instrument designed to assess the quality of nursing documentation, including nursing diagnoses, nursing interventions, and nursing-sensitive patient outcomes.
The instrument consists of four domains: Nursing Diagnoses as Process, Nursing Diagnoses as Outcomes, Nursing Interventions, and Nursing-Sensitive Patient Outcomes.
Higher scores indicate higher quality and more comprehensive documentation of nursing diagnoses, interventions, and patient outcomes in nursing care plans.
|
After completion of the educational intervention (approximately 4 weeks after baseline) and at the end of the clinical practice period (approximately 12 weeks after baseline).
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Nursing Process Knowledge Level Assessment Form
Periodo de tiempo: At baseline and at the end of the clinical practice period (approximately 12 weeks after baseline).
|
Students' knowledge of the nursing process will be evaluated using the Nursing Process Knowledge Level Assessment Form developed by the researcher.
The form consists of 25 multiple-choice questions.
The questions assess students' knowledge related to the nursing process, including assessment, nursing diagnosis, planning, implementation, and evaluation stages.
The form was reviewed by three experts, and necessary revisions were made in line with expert feedback.
Higher scores indicate a higher level of knowledge regarding the nursing process.
|
At baseline and at the end of the clinical practice period (approximately 12 weeks after baseline).
|
|
Instructional Materials Motivation Survey
Periodo de tiempo: At the end of the clinical practice period (approximately 12 weeks after baseline).
|
Students' learning motivation will be evaluated using the Instructional Materials Motivation Survey (IMMS), which is based on Keller's ARCS (Attention, Relevance, Confidence, Satisfaction) motivation model.
The survey consists of 24 items and two subscales: Attention-Relevance and Confidence-Satisfaction.
The Attention-Relevance subscale evaluates students' interest in and perceived relevance of the instructional content, whereas the Confidence-Satisfaction subscale assesses students' confidence and satisfaction with the learning experience.
Responses are rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree).
Total scores range from 24 to 120, with higher scores indicating higher levels of learning motivation.
|
At the end of the clinical practice period (approximately 12 weeks after baseline).
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Silla de estudio: Funda Büyükyılmaz, Professor, Istanbul University-Cerrahpasa, Florence Nightingale Faculty of Nursing
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
9 de abril de 2026
Finalización primaria (Estimado)
30 de junio de 2026
Finalización del estudio (Estimado)
30 de junio de 2026
Fechas de registro del estudio
Enviado por primera vez
23 de junio de 2026
Primero enviado que cumplió con los criterios de control de calidad
30 de junio de 2026
Publicado por primera vez (Actual)
1 de julio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
1 de julio de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
30 de junio de 2026
Última verificación
1 de junio de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 2025-749
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Descripción del plan IPD
Individual participant data will not be shared because the study involves educational data collected from nursing students, and participant confidentiality and privacy will be protected in accordance with ethical approval and institutional regulations.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .